Fighting Allergy with Allergen

Babies who ate peanuts were less likely to develop an allergy to the food by the time they hit kindergarten, according to a new study.

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, FREESTOCK.CAInfants at high risk of peanut allergies who were exposed to the food ended up less likely to develop the allergy later in life, according to a study published in the New England Journal of Medicine yesterday (February 23). Although the general practice for more than decade has been for babies to steer clear of peanuts, the results give a swift kick to advice that was falling out of favor.

“This study really proves cause and effect,” Hugh Sampson, a pediatric allergist at the Icahn School of Medicine at Mount Sinai in New York City, told Science. “When someone asks me in my practice, I will encourage them to get peanuts in the diet in the first year of life.”

The study randomly assigned more than 500 babies to either eat at least six grams of peanut protein a week or to abstain from peanuts. All of the babies had eczema or an egg allergy, but did not initially have a reaction to peanuts. At five years of age, nearly 14 percent of the abstinent group had developed a peanut allergy, compared to roughly 2 percent of the peanut-eating kids.

“This is a major study—really ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies